|
Volumn 14, Issue 2, 1997, Pages 241-245
|
Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy
a a,b,c |
Author keywords
Bladder cancer; Mitomycin C analog; Pharmacodynamics
|
Indexed keywords
7 N [2 (4 NITROPHENYLDITHIO)ETHYL]MITOMYCIN C;
MITOMYCIN C;
MITOMYCIN C DERIVATIVE;
UNCLASSIFIED DRUG;
ARTICLE;
BLADDER TUMOR;
CELL CULTURE;
CELL LINE;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE RESPONSE;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
PRIORITY JOURNAL;
TUMOR CELL;
ADMINISTRATION, INTRAVESICAL;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CARCINOMA, SQUAMOUS CELL;
CARCINOMA, TRANSITIONAL CELL;
CELL SURVIVAL;
MITOMYCIN;
MITOMYCINS;
TUMOR CELLS, CULTURED;
URINARY BLADDER NEOPLASMS;
|
EID: 0030938583
PISSN: 07248741
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012069231506 Document Type: Article |
Times cited : (1)
|
References (22)
|